Nuclear transcription factor Y subunit gamma (275-282)

Nuclear transcription factor Y subunit gamma

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-224

Synonyms/Alias:Nuclear transcription factor Y subunit gamma (275-282)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
QQITKTEV
Areas of Interest
Antigen-presenting Cells; Cancer Research

Nuclear transcription factor Y subunit gamma (275-282) is a synthetic peptide fragment derived from the C-terminal region of the NF-YC protein, an essential component of the heterotrimeric NF-Y transcription factor complex. This peptide segment encompasses amino acids 275 to 282 of the gamma subunit, a region implicated in protein-protein interactions and regulatory functions within the NF-Y complex. As NF-Y is a highly conserved transcription factor that binds to CCAAT motifs in promoter regions, the gamma subunit plays a pivotal role in DNA binding specificity and complex stability. The availability of this defined peptide sequence provides researchers with a targeted tool for dissecting the molecular mechanisms underlying transcriptional regulation, protein complex assembly, and related cellular processes.

Peptide mapping: Researchers utilize the 275-282 fragment of the NF-YC subunit in peptide mapping experiments to identify and characterize specific protein interaction domains within the NF-Y complex. By synthesizing and analyzing this peptide, scientists can investigate the minimal sequence requirements for subunit association, delineate critical contact points for heterotrimer formation, and map the structural determinants necessary for transcription factor assembly. Such studies contribute to a refined understanding of transcriptional regulation at the molecular level.

Antibody epitope mapping: The defined sequence of the NF-YC (275-282) peptide serves as a valuable antigenic epitope for generating and validating antibodies specific to the C-terminal region of the gamma subunit. In immunological assays, this peptide can be employed to assess antibody specificity, facilitate the development of peptide-based detection reagents, and support immunoprecipitation or immunoblotting studies targeting NF-YC. Utilizing a synthetic epitope ensures precise and reproducible antibody responses, enhancing the reliability of protein localization and quantification efforts.

Protein-protein interaction studies: The 275-282 peptide fragment is instrumental in probing direct binding interactions between NF-YC and its regulatory partners. In vitro assays employing this peptide allow researchers to dissect the contribution of the C-terminal region to complex formation with other NF-Y subunits or co-regulatory proteins. By introducing the peptide as a competitive inhibitor or affinity ligand, investigators can elucidate binding affinities, identify interaction motifs, and characterize modulatory effects on transcriptional activity.

Post-translational modification analysis: The synthetic peptide corresponding to NF-YC (275-282) provides a defined substrate for investigating potential post-translational modifications, such as phosphorylation, acetylation, or methylation, that may occur within this region. In vitro modification assays and mass spectrometry analyses using this peptide enable the identification of specific modification sites and facilitate studies on how these alterations influence NF-YC function, stability, or interactions within the transcription factor complex.

Peptide-based assay development: The availability of a well-characterized NF-YC (275-282) peptide supports the design and optimization of biochemical assays aimed at quantifying peptide-protein interactions, screening for small molecule modulators, or monitoring enzymatic activity related to the gamma subunit. Such assays are critical for high-throughput screening applications, structure-activity relationship studies, and the development of molecular probes targeting the transcriptional machinery. Employing a synthetic peptide ensures assay reproducibility and specificity, advancing research into NF-Y-mediated gene regulation.

Source#
Homo sapiens (human)
Epitope
275-282
Restricting HLA
HLA-B52
References
Takenoyama; Int J Cancer  2006

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide CDMOcGMP Peptide ServicePeptide Modification ServicesPeptide Analysis ServicesEpitope Mapping ServicesPeptide Synthesis ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers